Reply to the reply to Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future …
Main Authors: | Guillaume Desoubeaux, Adrien Lemaignen, Stephan Ehrmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971220302216 |
Similar Items
-
Treatment of Pneumocystis jirovecii Pneumonia with Caspofungin and Clindamycin: An HIV Patient and Literature Review
by: Gül Ruhsar YILMAZ, et al.
Published: (2024-03-01) -
Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future…
by: Guillaume Desoubeaux, et al.
Published: (2020-06-01) -
The Long-Acting Echinocandin, Rezafungin, Prevents Pneumocystis Pneumonia and Eliminates Pneumocystis from the Lungs in Prophylaxis and Murine Treatment Models
by: Melanie T. Cushion, et al.
Published: (2021-09-01) -
Immune reconstitution inflammatory syndrome in splenic Pneumocystis jirovecii infection: A case report
by: Hiroki Kojima, et al.
Published: (2023-01-01) -
El neumomediastino, una complicación rara de Pneumocystis Jirovecii
by: Daniela Neto, et al.
Published: (2023-09-01)